Q3 Earnings Estimate for Transcat Issued By Northland Capmk

Transcat, Inc. (NASDAQ:TRNS) – Northland Capmk issued their Q3 2025 earnings estimates for shares of Transcat in a report released on Wednesday, October 30th. Northland Capmk analyst E. Jackson expects that the scientific and technical instruments company will post earnings per share of $0.41 for the quarter. The consensus estimate for Transcat’s current full-year earnings is $2.06 per share. Northland Capmk also issued estimates for Transcat’s Q4 2025 earnings at $0.63 EPS and FY2029 earnings at $3.45 EPS.

TRNS has been the subject of a number of other reports. HC Wainwright reissued a “buy” rating and issued a $156.00 price target on shares of Transcat in a research report on Tuesday. Craig Hallum decreased their target price on shares of Transcat from $138.00 to $113.00 and set a “buy” rating for the company in a research note on Wednesday. Northland Securities dropped their price target on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a research note on Wednesday. Oppenheimer reissued an “outperform” rating and set a $130.00 price objective (down previously from $155.00) on shares of Transcat in a research report on Wednesday. Finally, StockNews.com lowered Transcat from a “hold” rating to a “sell” rating in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $127.25.

Transcat Trading Down 3.5 %

Shares of NASDAQ TRNS opened at $95.57 on Thursday. Transcat has a one year low of $84.45 and a one year high of $147.12. The business has a 50-day moving average price of $122.34 and a two-hundred day moving average price of $121.99. The firm has a market capitalization of $874.47 million, a PE ratio of 56.55 and a beta of 0.67.

Transcat (NASDAQ:TRNS) last issued its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.12). The business had revenue of $67.83 million during the quarter, compared to analyst estimates of $70.30 million. Transcat had a return on equity of 8.48% and a net margin of 5.69%. The business’s quarterly revenue was up 8.0% on a year-over-year basis. During the same period last year, the business earned $0.41 EPS.

Institutional Investors Weigh In On Transcat

A number of large investors have recently bought and sold shares of TRNS. Diversified Trust Co lifted its position in shares of Transcat by 23.6% in the first quarter. Diversified Trust Co now owns 3,010 shares of the scientific and technical instruments company’s stock worth $335,000 after buying an additional 575 shares during the last quarter. BNP Paribas Financial Markets raised its stake in shares of Transcat by 24.2% in the 1st quarter. BNP Paribas Financial Markets now owns 14,024 shares of the scientific and technical instruments company’s stock valued at $1,563,000 after acquiring an additional 2,737 shares in the last quarter. Essex Investment Management Co. LLC lifted its holdings in Transcat by 1.5% in the 1st quarter. Essex Investment Management Co. LLC now owns 37,435 shares of the scientific and technical instruments company’s stock worth $4,171,000 after purchasing an additional 569 shares during the last quarter. Swiss National Bank boosted its position in Transcat by 1.2% during the first quarter. Swiss National Bank now owns 17,415 shares of the scientific and technical instruments company’s stock worth $1,941,000 after purchasing an additional 200 shares during the period. Finally, Russell Investments Group Ltd. grew its holdings in Transcat by 8.6% during the first quarter. Russell Investments Group Ltd. now owns 26,713 shares of the scientific and technical instruments company’s stock valued at $2,977,000 after purchasing an additional 2,121 shares during the last quarter. 98.34% of the stock is currently owned by institutional investors.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.